Sildenafil — Drug Intelligence | 5 EU Trials

Filter these 5 trials by condition, phase, country and more.

5 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

4 Countries

Phase III

Phase II/III

Phase I/II

Phase IV

Phase III: 2 Phase II/III: 1 Phase I/II: 1 Phase IV: 1

Oversight events:

1 corrective measure across 1 trial

Indications tested

5 total

Effect of Sildenafil in association to Hypothermia on survival without brain lesions In term Neonates with hypoxic-ischemic Encephalopathy: … Pending

2023-508928-35-00 Phase II/III 1 country Assistance Publique Hopitaux De Paris
Interest of early erectile rehabilitation with Sildenafil after proctectomy for rectal cancer : Randomized controlled trial (RECTIL) Recruiting

2024-515431-30-00 Phase III 1 country Centre Hospitalier Universitaire Rouen
The use of sildenafil in patients with univentricular heart after Fontan operation - a pilot SINFON-POL study. Recruiting

2023-503913-31-01 Phase III 1 country National Institute Of Cardiology
PEHAB II Recruiting

2023-507466-40-00 Phase IV 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
The headache-inducing effects of sildenafil in men and women with episodic migraine without aura. Ended

2024-512014-17-02 Phase I/II 1 country Syddansk Universitet (University of Southern Denmark)

Showing 1–5 of 5 trials